Six weeks after Rwanda-backed rebels captured the eastern Congolese cities of Goma and Bukavu, the region is facing a setback ...

ACTG, a global clinical trials network focused on HIV and other infectious diseases, recently presented data demonstrating ...

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...

More than 200 community health agents have already been trained in Burundi to help control the spread of mpox as the ...

Tanzania has officially declared the end of an outbreak of Marburg virus disease that hit the northwestern Kagera region in January. But officials are still bracing for the ongoing threat of Mpox.

Tanzania has confirmed its first two cases of mpox, the health ministry said Monday, the first time the virus has been ...

Nurses are administering medicine to Mpox patients at a tent in Kabare, Democratic Republic of the Congo, as the area ...

A NIH-led trial found tecovirimat ineffective in reducing mpox lesion healing time or pain relief. The study was halted in 2024, with findings presented at CROI 2025.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Severe mpox and long-term sequelae such as severe scarring were more likely to occur among HIV-positive patients with detectable viral loads and low CD4 counts.

In eastern Congo, mpox detection and treatment face setbacks amid a rebel offensive backed by Rwanda. Hospitals suffer from ...